| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.21 | 9e-08 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.3 | 3e-07 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.28 | 3e-06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.26 | 3e-06 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.33 | 5e-06 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |